Blogs

Development in gene therapies is continually increasing – presently over 1,400 companies are involved, with over 2,200 clinical trials underway. It is essential to find an appropriate containment system to protect the time and monetary investments required to create these treatments.

Margaret Craig

June 24, 2025

West is pleased to welcome guest blogger and valued corporate partner The American Red Cross

American Red Cross

June 16, 2025

Annex 1 of the European Union’s Good Manufacturing Practice guidelines (EU GMP Annex 1) has loomed large over the manufacture of parenteral products since it was first introduced in August 2022.

Victoria Morgan

June 05, 2025

Among the many sessions at the recent Parenteral Drug Association Week (formerly PDA Annual Meeting) in Palm Springs, CA, several focused on advanced therapy medicinal products (e.g., cell therapies, gene therapies), biosimilars, and disruptive therapies (e.g., live biotherapeutic products). With the growth of these therapies, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50^oC to ≤ -130^oC.

Amy Rovi

May 29, 2025